US signs $450m deal with Regeneron for Covid-19 treatment
The US is funding manufacturing and trials for potential vaccines and has secured billions of doses for use by Americans
07 July 2020 - 16:37
Bengaluru — The US government has signed a $450m contract with Regeneron Pharmaceuticals for its potential Covid-19 antibody cocktail.
The agreement, the first by the Trump administration to support a therapy, comes under the government’s “operation warp speed” programme aimed at faster distribution of vaccines and treatments to fight the new coronavirus when trials are successful...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.